Suzhou Ribo Life Science Co Ltd

Capital Structure and Liquidity Suzhou Ribo Life Science Co Ltd exhibits a negative total equity of CNY -93.94 million and a debt-to-equity ratio of -5.86, indicating a leveraged capital structure with liabilities exceeding assets. The company holds CNY 406.75 million in cash and equivalents, but this is offset by CNY 550.07 million in long-term debt, resulting in a net cash position of CNY -143.32 million. The current ratio of 0.86 suggests limited short-term liquidity, as current assets fall short of current liabilities. ### Profitability and Returns The company reported a revenue of CNY 148.51 million, with a gross profit of CNY 121.73 million, translating to a gross margin of 81.97%. However, it recorded an operating loss of CNY 263.12 million and a net loss of CNY 278.06 million, indicating significant operational inefficiencies. The return on equity (ROE) is 2.96, while the return on assets (ROA) is -0.33, reflecting poor asset utilization and profitability. ### Segments and Geographic Exposure The company's revenue is not disclosed by segment or geography in the available data. As a result, it is not possible to assess revenue concentration or geographic diversification at this time. ### Growth Trajectory The company's recent financial performance shows a decline in profitability, with a net loss of CNY 278.06 million. Analysts have provided a mean price target of CNY 105.78, with a median of CNY 103.23, suggesting some optimism about future performance. However, the absence of revenue growth data and the current net loss indicate a challenging growth trajectory. ### Risk Factors The company faces medium liquidity risk due to its negative net cash position and high debt levels. The risk of dilution is assessed as low, but the company's negative equity and operating cash flow of CNY -280.69 million suggest potential financial stress. Adjustments in valuation metrics reflect the company's poor financial health. ### Recent Events No specific recent events, such as filings or transcripts, are provided in the available data to inform the company's current status.